Featured Research

from universities, journals, and other organizations

New markers could improve treatment and survival in acute lymphoblastic leukemia

Date:

December 21, 2012

Source:

Basque Research

Summary:

Acute lymphoblastic leukemia, the most common pediatric cancer, has been the subject of a new study. Newly identified genetic markers could improve the classification of risk groups and predict treatment toxicity in the patient.

Share This

Acute lymphoblastic leukemia, the most common pediatric cancer, has been the subject of study in the PhD thesis of Elixabet López. In the work entitled "New genetic markers for treatment personalization in paediatric Acute Lymphoblastic leukemia," the UPV/EHU biologist has presented new genetic markers that could improve the classification of risk groups and predict treatment toxicity in the patient. That way it would be possible to achieve better personalisation of the treatment.

Related Articles

Over the last few decades survival has increased from 10% to 80%. This improvement has been achieved by using combined therapies and separating the patients into risk groups. For example, stronger treatment is used in the groups in which a worse response is expected. That way the survival probability in the groups with a poor prognosis is increased, while chemotherapy toxicity in patients with a better prognosis is reduced.

However, the classification of the risk groups, which today is carried out by means of clinical markers, like the number of lymphocytes or age of the patient, and some genetic markers, is not totally exact. For example, some of the patients initially considered as lower risk do not respond well to the treatment and in the middle of their treatment their therapy is changed to that of greater risk. In these cases, "survival could be improved as the condition would be treated more intensively right from the start," points out López.

On the other hand, children with acute lymphoblastic leukemia receive very strong doses of chemotherapy, and toxicity problems, which can be very serious, often occur. What is more, "as they are children and the toxicity can leave them with sequelae for the rest of their lives, it is quite important to try and prevent it," says López. Currently, there is no toxicity marker that is used in a standard way.

Quest for new markers

To find new risk markers, the whole genome of tumour cells was combed in the search for deletions and duplications. And the ones that were recurrent and which were exclusive to a risk group were selected, and so were the ones that were found in the patients who were moved from one group to another. "We have found a low risk marker which only appears in low risk patients and another that only appears in high risk ones, which could complement the ones that are already being used. And another 5 markers that appear in patients that were changed from low risk to high risk, and in those of high risk. This means that those patients were in fact high risk ones and that they should have been included in that group," explains the author.

On the other hand, the toxicity markers were sought in normal cells to detect variations that are of the individual and not of the tumour. This study has focussed on methotrexate, one of the most important drugs that can cause toxicity. And several possible markers have been found, like some variants of the methotrexate transporter gene and other variants related to microRNAs (short ribonucleic acid molecules which do not give rise to proteins but which carry out a significant regulatory function) that regulate the genes.

López's next aim is to study how the genetic variations found affect gene expression and see exactly why these variations are regulating toxicity or response to treatment. Furthermore, to validate the markers, they are endeavouring to set up some clinical trials. "We have found these associations in our population, but a clinical trial would be needed to see whether they really are good markers and whether, in actual fact, survival and toxicity are improved when these markers are used," says López.

Story Source:

The above story is based on materials provided by Basque Research. Note: Materials may be edited for content and length.

Featured Research

Mar. 31, 2015 — Researchers have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPAR alpha which activates liver ... full story

Mar. 31, 2015 — Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015 — Fewer than half of the physicians trained in the United States in 2013 received formal education or training on the subject of exercise, according to new research. "There are immense medical benefits ... full story

Mar. 31, 2015 — Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015 — Increasing state alcohol taxes could prevent thousands of deaths a year from car crashes, say researchers, who found alcohol-related motor vehicle crashes decreased after taxes on beer, wine and ... full story

Mar. 31, 2015 — Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015 — A new population of 'memory' immune cells has been discovered by scientists, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will ... full story

Mar. 31, 2015 — Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015 — A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Featured Videos

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports.
Video provided by Reuters

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Diné Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline.
Video provided by Washington Post

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17
Video provided by AFP

Related Stories

Aug. 25, 2014 — Weekend admission to the hospital for pediatric patients newly diagnosed with leukemia was associated with a longer length of stay, slightly longer wait to start chemotherapy and higher risk for ... full story

July 31, 2014 — In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers report that they have identified a ... full story

May 11, 2010 — A genetic pattern that predicts the likelihood of relapse in patients with one of the most aggressive forms of childhood leukemia has been discovered. Researchers have identified a consistent pattern ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.